Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-018752
Filing Date
2024-04-09
Accepted
2024-04-09 08:34:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20019772x3_defa14a.htm DEFA14A 6313
2 ny20019772x3_nc01.jpg GRAPHIC 347815
3 ny20019772x3_nc02.jpg GRAPHIC 208139
  Complete submission text file 0001140361-24-018752.txt   773463
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39503 | Film No.: 24831228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)